CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
70.17
+1.57 (2.29%)
At close: Aug 18, 2025, 4:00 PM
70.10
-0.07 (-0.10%)
After-hours: Aug 18, 2025, 7:59 PM EDT
CVS Health Stock Forecast
Stock Price Forecast
The 16 analysts that cover CVS Health stock have a consensus rating of "Strong Buy" and an average price target of $76.94, which forecasts a 9.65% increase in the stock price over the next year. The lowest target is $62 and the highest is $84.
Price Target: $76.94 (+9.65%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 3 | 4 | 4 | 5 |
| Buy | 8 | 8 | 8 | 8 | 8 | 10 |
| Hold | 3 | 3 | 3 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 14 | 15 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold → Strong Buy Upgrades $67 → $79 | Hold → Strong Buy | Upgrades | $67 → $79 | +12.58% | Aug 18, 2025 |
| Baird | Baird | Hold → Buy Upgrades $71 → $82 | Hold → Buy | Upgrades | $71 → $82 | +16.86% | Aug 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $80 → $82 | Buy | Maintains | $80 → $82 | +16.86% | Aug 1, 2025 |
| Barclays | Barclays | Buy Maintains $79 → $80 | Buy | Maintains | $79 → $80 | +14.01% | Aug 1, 2025 |
| UBS | UBS | Hold Maintains $71 → $67 | Hold | Maintains | $71 → $67 | -4.52% | Jul 22, 2025 |
Financial Forecast
Revenue This Year
390.68B
from 370.66B
Increased by 5.40%
Revenue Next Year
406.43B
from 390.68B
Increased by 4.03%
EPS This Year
6.20
from 3.66
Increased by 69.27%
EPS Next Year
7.09
from 6.20
Increased by 14.50%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 422.4B | 444.7B | 481.5B | ||
| Avg | 390.7B | 406.4B | 430.9B | ||
| Low | 374.0B | 380.5B | 385.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.0% | 13.8% | 18.5% | ||
| Avg | 5.4% | 4.0% | 6.0% | ||
| Low | 0.9% | -2.6% | -5.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.83 | 8.18 | 9.45 | ||
| Avg | 6.20 | 7.09 | 8.08 | ||
| Low | 5.89 | 5.98 | 6.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.5% | 32.0% | 33.2% | ||
| Avg | 69.3% | 14.5% | 13.9% | ||
| Low | 60.9% | -3.5% | -10.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.